These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9430878)

  • 1. Castleman's disease with renal amyloidosis and nephrotic syndrome.
    Arinsoy T; Yilmaz M; Ataoğlu O; Bali M; Sindel S
    Nephrol Dial Transplant; 1997 Dec; 12(12):2713-6. PubMed ID: 9430878
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of nephrotic syndrome with colchicine therapy secondary to amyloidosis with associated Castleman's disease.
    Paydas S; Gonlusen G; Sagliker Y
    Nephron; 1995; 71(4):463-4. PubMed ID: 8587630
    [No Abstract]   [Full Text] [Related]  

  • 3. Castleman's disease with nephrotic syndrome, amyloidosis and autoimmune manifestations.
    Curioni S; D'Amico M; Quartagno R; Martino S; Dell'Antonio G; Cusi D
    Nephrol Dial Transplant; 2001 Jul; 16(7):1475-8. PubMed ID: 11427644
    [No Abstract]   [Full Text] [Related]  

  • 4. Remission of nephrotic syndrome after removal of localized Castleman's disease.
    Keven K; Nergizoğlu G; Ateş K; Erekul S; Orhan D; Ertürk S; Tulunay O; Karatan O; Ertuğ AE
    Am J Kidney Dis; 2000 Jun; 35(6):1207-11. PubMed ID: 10845836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Highly thrombogenic forms of Behçet's disease associated with Castleman's disease and renal amyloidosis].
    Belgnaoui F; Raki S; Douira L; Benabdellah L; Rimani M; Labraïmi A; Aouni M; Senouci K; Hassam B
    Ann Dermatol Venereol; 2006 Mar; 133(3):278-80. PubMed ID: 16800185
    [No Abstract]   [Full Text] [Related]  

  • 6. Fatal diarrhea in a patient with Castleman's disease associated with intestinal amyloidosis.
    Miura A; Sato I; Suzuki C
    Intern Med; 1995 Nov; 34(11):1106-9. PubMed ID: 8774974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotic syndrome associated with angiofollicular lymph node hyperplasia, and subsequent amyloidosis.
    Chan KW; Lo WK; Cheng IK
    Pathology; 1992 Jul; 24(3):229-30. PubMed ID: 1437301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephrotic Syndrome Caused by AA Amyloidosis Secondary to Unicentric Castleman's Disease:Report of One Case].
    You RL; Wen YB; Wang J; Ma J; Chen LM; Li XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Jun; 44(3):540-544. PubMed ID: 35791957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary amyloidosis associated with Castleman's disease.
    Tanaka K; Horita M; Shibayama H; Seike M; Itoh Y; Hamaguchi K; Sato Y; Sakata T; Ishida T
    Intern Med; 1995 Feb; 34(2):122-6. PubMed ID: 7727877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-stage renal failure from renal amyloidosis of the AA type associated with giant lymph node hyperplasia (Castleman's disease).
    Montoli A; Minola E; Stabile F; Grillo C; Radaelli L; Spanti D; Luccarelli E; Spata C; Minetti L
    Am J Nephrol; 1995; 15(2):142-6. PubMed ID: 7733151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and nephrotic syndrome due to renal amyloidosis.
    Feitelson PJ; Ortiz R; Lindheimer MD
    Am J Obstet Gynecol; 1971 Sep; 111(2):306-7. PubMed ID: 5098601
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinico-pathological study of renal amyloidosis in northern India.
    Vaishnava H; Gulati PD; Aurora AL
    J Assoc Physicians India; 1969 Nov; 17(11):641-50. PubMed ID: 5356699
    [No Abstract]   [Full Text] [Related]  

  • 13. Amyloidosis in chronic heroin addicts with the nephrotic syndrome.
    Scholes J; Derosena R; Appel GB; Jao W; Boyd MT; Pirani CL
    Ann Intern Med; 1979 Jul; 91(1):26-9. PubMed ID: 464449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Castleman disease with secondary AA renal amyloidosis, nephrotic syndrome and chronic renal failure, remission after high-dose melphalan and autologous stem cell transplantation.
    Ogita M; Hoshino J; Sogawa Y; Sawa N; Katori H; Takemoto F; Ubara Y; Hara S; Miyakoshi S; Takaichi K
    Clin Nephrol; 2007 Sep; 68(3):171-6. PubMed ID: 17915620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grand rounds--Hammersmith Hospital. Reactive (AA) systemic amyloidosis. A cause of refractory nephrotic syndrome.
    BMJ; 1996 Apr; 312(7038):1087-9. PubMed ID: 8616421
    [No Abstract]   [Full Text] [Related]  

  • 16. [The characteristics of the nephrotic syndrome in patients with renal amyloidosis].
    Shishkin AN; Shulutko TA
    Lik Sprava; 1993; (5-6):80-3. PubMed ID: 8209508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castleman disease and renal amyloidosis.
    Kazes I; Deray G; Jacobs C
    Ann Intern Med; 1995 Mar; 122(5):395-6. PubMed ID: 7847660
    [No Abstract]   [Full Text] [Related]  

  • 18. Remission of nephrotic syndrome after thalidomide therapy in a patient with Castleman's disease.
    Menegato MA; Canelles MF; Tonutti E; Pizzolitto S
    Clin Nephrol; 2004 May; 61(5):352-6. PubMed ID: 15182131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literature.
    Ordi J; Grau JM; Junqué A; Nomdedeu B; Palacin A; Cardesa A
    Am J Clin Pathol; 1993 Oct; 100(4):394-7. PubMed ID: 8213634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term remission of the nephrotic syndrome in renal amyloidosis].
    Valentik MF; Tov NL
    Ter Arkh; 1986; 58(8):101-2. PubMed ID: 3764749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.